Indication
AUGTYRO™ (repotrectinib) is a prescription medicine used to treat adults and children 12 years and older with solid tumors (cancer) that are caused by certain abnormal NTRK genes and have spread, or if surgery to remove their cancer is likely to cause severe complications.
It is not known if AUGTYRO is safe and effective in children younger than 12 years of age.
See another indicationAUGTYRO with You
AUGTYRO (repotrectinib) may cause serious side effects, including central nervous system (CNS) effects, lung problems (pneumonitis), liver problems, muscle problems, increased uric acid level in your blood (hyperuricemia), and bone fractures.
Important Facts
about AUGTYRO™ (repotrectinib)
This is a summary of important information that you need to know about AUGTYRO. Your healthcare team can work with you to help answer any questions you may have about this medication. Keep this document in a safe place, so you can refer to it before and during your treatment.
Look out for the following
icons as you read:
Talk to your healthcare team
Call a healthcare provider right away
Helpful information to remember
What is AUGTYRO?
AUGTYRO (repotrectinib) is an oral prescription medicine used to treat adults and children 12 years and older with solid tumors (cancer) that:
It is not known if AUGTYRO is safe and effective in children younger than 12 years of age with NTRK-positive solid tumors.
What is the most important information I should know about AUGTYRO?
AUGTYRO may cause serious side effects. A serious side effect is a side effect that can sometimes become life-threatening and can lead to death. The serious side effects of AUGTYRO may include:
Central nervous system (CNS) problems. Symptoms to look out for include:
Call your healthcare provider right away if you have any of these symptoms, or any worsening of CNS effects during treatment.
Lung problems (pneumonitis). AUGTYRO may cause pneumonitis (inflammation of the lungs), which may be severe or serious. New or worsening symptoms to look out for include:
Call your healthcare provider right away if you have any of these symptoms, or any worsening of your current lung problems.
Liver problems. Your healthcare provider will do blood tests to check your liver function before starting treatment with AUGTYRO™, every 2 weeks for the first month, and as needed during treatment. Symptoms of liver problems include:
Call your healthcare provider right away if you develop any of these symptoms of liver problems.
Muscle problems. Your healthcare provider will do blood tests before starting treatment with AUGTYRO, every 2 weeks for the first month, and as needed during treatment. Symptoms of muscle problems include:
Call your healthcare provider right away if you get new or worsening signs and symptoms of muscle problems.
Increased uric acid level in your blood (hyperuricemia). AUGTYRO may cause an excess of uric acid in your blood. Your healthcare provider will do tests before and during your treatment with AUGTYRO to check the uric acid level in your blood. Your healthcare provider may prescribe medications if you have high blood uric acid levels. Tell your healthcare provider if you experience symptoms of increased uric acid, including:
Bone fractures. AUGTYRO may increase your risk for bone fractures. Bone fractures may happen with or without a fall or other injury.
Call your healthcare provider right away if you have pain, changes in movement, or bone abnormalities.
What should I discuss with my healthcare team before starting treatment?
Talk to your healthcare provider about all your medical conditions, including if you:
Talk to your healthcare team about all the medicines you are taking, including:
Taking AUGTYRO with certain other medicines may:
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
These are not all the topics you should discuss with your healthcare team. Discuss any questions you may have with your healthcare team.
What should I discuss with my healthcare team about pregnancy, birth control, and breastfeeding before starting treatment?
Talk to your healthcare team if:
You are pregnant or plan to become pregnant — AUGTYRO™ may harm your unborn baby
If you are able to become pregnant, your healthcare team should do a pregnancy test before you start treatment with AUGTYRO.
If you are able to become pregnant, you should use effective non-hormonal birth control (contraception) during treatment and for 2 months after your last dose of AUGTYRO.
Birth control methods that contain hormones (such as birth control pills, injections, or transdermal system patches) may not work as well during treatment with AUGTYRO.
Talk to your healthcare team about birth control methods that may be right for you.
Call your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with AUGTYRO.
You are a male with a female partner who is able to become pregnant
You should use effective birth control during treatment with AUGTYRO and for 4 months after your last dose.
Call your healthcare provider right away if your partner becomes pregnant during treatment with AUGTYRO.
You are breastfeeding or plan to breastfeed
Do not breastfeed during treatment and for 10 days after the last dose of AUGTYRO. It is not known if AUGTYRO passes into your breast milk. Talk to your healthcare team about the best way to feed your baby during this time.
What are the most common side effects of AUGTYRO?
The most common side effects of AUGTYRO include:
These are not all the possible side effects. Talk to your doctor for more information about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.
How should AUGTYRO™ be taken?
Take AUGTYRO exactly as your healthcare provider tells you. The number of pills that you take will depend on your dose. Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with AUGTYRO if you develop side effects. Do not change your dose or stop taking AUGTYRO without first talking to your healthcare provider.
AUGTYRO is a capsule with a white opaque cap and body, filled with a white to off-white powder. “REP 40” is printed in blue text on the cap.
Inactive ingredients: microcrystalline cellulose, sodium lauryl sulfate, croscarmellose sodium, and colloidal silicon dioxide.
Capsule coating inactive ingredients: gelatin and titanium dioxide.
Printing ink: shellac and FD & C blue #2 aluminum lake.
OR
AUGTYRO is a capsule with a blue opaque cap and body, filled with a white to off-white powder. "REP 160" is printed in white text on the cap.
Inactive ingredients: microcrystalline cellulose, sodium lauryl sulfate, croscarmellose sodium, magnesium stearate, and colloidal silicon dioxide.
Capsule coating inactive ingredients: gelatin and titanium dioxide.
Printing ink: shellac, titanium dioxide, and FD & C blue #1.
What if I miss a dose of AUGTYRO?
If you miss a dose or vomit at any time after taking a dose of AUGTYRO, do not take an extra dose. Just skip the dose and take your next dose at the regularly scheduled time. Do not take 2 doses at the same time to make up a missed or vomited dose.
How do I store AUGTYRO?
AUGTYRO capsules should be stored at room temperature between 68°F to 77°F (20°C to 25°C).
Keep AUGTYRO and all medicines out of the reach of children.
For more information, please see accompanying U.S. Full Prescribing Information and Patient Information for AUGTYRO. Talk to your healthcare team for more information about this medication.